Biotech · Public company · Boca Raton, FL, US

Inmune Bio, Inc.

Ticker INMB · SEC CIK 0001711754

Track this companyFree. Adds Inmune Bio, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials20 recruiting or active

Pipeline programs2From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline2

INB03Phase 3 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
INKmunePhase 2 · CancerClinicalTrials.gov · fetched Nov 12, 2026

Clinical trials2

Study of INKmune in Patients With mCRPC (CaRe Prostate)PHASE1_PHASE2 · COMPLETED · started Nov 30, 2023ClinicalTrials.gov NCT06056791 · fetched Nov 12, 2026
INB03 for the Treatment of Pulmonary Complications From COVID-19PHASE2_PHASE3 · TERMINATED · started Oct 21, 2020ClinicalTrials.gov NCT04370236 · fetched Nov 12, 2026

SEC filings12

10-Q · QUARTERLY REPORTSEC EDGAR · filed Nov 5, 2026 · fetched Nov 12, 2026
8-K · CURRENT REPORTSEC EDGAR · filed Oct 29, 2026 · fetched Nov 12, 2026
8-K · CURRENT REPORTSEC EDGAR · filed Oct 21, 2026 · fetched Nov 12, 2026
8-K · CURRENT REPORTSEC EDGAR · filed Sep 14, 2026 · fetched Nov 12, 2026
10-Q · QUARTERLY REPORTSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
8-K · CURRENT REPORTSEC EDGAR · filed Jul 31, 2026 · fetched Nov 12, 2026
8-K · CURRENT REPORTSEC EDGAR · filed Jul 1, 2026 · fetched Nov 12, 2026
8-K · CURRENT REPORTSEC EDGAR · filed Jun 23, 2026 · fetched Nov 12, 2026
8-K · CURRENT REPORTSEC EDGAR · filed Jun 17, 2026 · fetched Nov 12, 2026
8-K · CURRENT REPORTSEC EDGAR · filed Jun 2, 2026 · fetched Nov 12, 2026
8-K · CURRENT REPORTSEC EDGAR · filed May 14, 2026 · fetched Nov 12, 2026
10-Q · QUARTERLY REPORTSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026